Positron Corporation (POSC)

[roelien]

Excerpt from the BMR Rooney interview

BiomedReports: I know you can’t get into too many details about some of the news that you’ll be discussing at the upcoming press conference, but are a few things you can share with us?

Rooney: I think we want to bring to market, exactly the position that the company is in. We do have some big important strategic alliances that we will be talking about for the first time. Some of them are already in contract form and we cannot discuss them until after early May, and others involve radiopharmaceutical companies that will be getting into the radiopharmaceutical market with us, in other words, they have the drug, but they may not have the device to image this drug on.